Global Chinese Patent Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chinese Patent Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Chinese Patent Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chinese Patent Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Online Sales and Offline Sales are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chinese Patent Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Chinese Patent Medicine key manufacturers include Shanghai Pharmaceutical (Group) Co., Ltd., China Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Co., Ltd, Nanjing Pharmaceutical Industry (Group) Co., Ltd., North China Pharmaceutical Group Co., Ltd., Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. and Taiji Group Co., Ltd., etc. Shanghai Pharmaceutical (Group) Co., Ltd., China Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Group Co., Ltd. are top 3 players and held % sales share in total in 2022.
Chinese Patent Medicine can be divided into Syrup, Liquid, Tablet and Others, etc. Syrup is the mainstream product in the market, accounting for % sales share globally in 2022.
Chinese Patent Medicine is widely used in various fields, such as Online Sales and Offline Sales, etc. Online Sales provides greatest supports to the Chinese Patent Medicine industry development. In 2022, global % sales of Chinese Patent Medicine went into Online Sales filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chinese Patent Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Shanghai Pharmaceutical (Group) Co., Ltd.
China Pharmaceutical Group Corporation
Guangzhou Pharmaceutical Group Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd
Nanjing Pharmaceutical Industry (Group) Co., Ltd.
North China Pharmaceutical Group Co., Ltd.
Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
Taiji Group Co., Ltd.
Xinhualu Anti-Pharmaceutical Group Co., Ltd.
Nanjing Pharmaceutical Co., Ltd
Chongqing Pharmaceutical Co., Ltd
Hangzhou Huadong Pharmaceutical Group Co., Ltd.
Jiangxi Pharmaceutical Group Corporation
Shijiazhuang Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Segment by Type
Syrup
Liquid
Tablet
Others
Online Sales
Offline Sales
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Chinese Patent Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chinese Patent Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chinese Patent Medicine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Chinese Patent Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chinese Patent Medicine introduction, etc. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Chinese Patent Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Chinese Patent Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Chinese Patent Medicine key manufacturers include Shanghai Pharmaceutical (Group) Co., Ltd., China Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Co., Ltd, Nanjing Pharmaceutical Industry (Group) Co., Ltd., North China Pharmaceutical Group Co., Ltd., Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. and Taiji Group Co., Ltd., etc. Shanghai Pharmaceutical (Group) Co., Ltd., China Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Group Co., Ltd. are top 3 players and held % sales share in total in 2022.
Chinese Patent Medicine can be divided into Syrup, Liquid, Tablet and Others, etc. Syrup is the mainstream product in the market, accounting for % sales share globally in 2022.
Chinese Patent Medicine is widely used in various fields, such as Online Sales and Offline Sales, etc. Online Sales provides greatest supports to the Chinese Patent Medicine industry development. In 2022, global % sales of Chinese Patent Medicine went into Online Sales filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chinese Patent Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Shanghai Pharmaceutical (Group) Co., Ltd.
China Pharmaceutical Group Corporation
Guangzhou Pharmaceutical Group Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd
Nanjing Pharmaceutical Industry (Group) Co., Ltd.
North China Pharmaceutical Group Co., Ltd.
Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
Taiji Group Co., Ltd.
Xinhualu Anti-Pharmaceutical Group Co., Ltd.
Nanjing Pharmaceutical Co., Ltd
Chongqing Pharmaceutical Co., Ltd
Hangzhou Huadong Pharmaceutical Group Co., Ltd.
Jiangxi Pharmaceutical Group Corporation
Shijiazhuang Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Segment by Type
Syrup
Liquid
Tablet
Others
Segment by Application
Online Sales
Offline Sales
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Chinese Patent Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chinese Patent Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chinese Patent Medicine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Chinese Patent Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chinese Patent Medicine introduction, etc. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Chinese Patent Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices